These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36352178)

  • 1. Development of transgenic mice overexpressing mouse carbonyl reductase 1.
    Yokoyama M; Fujita T; Kadonosawa Y; Tatara Y; Motooka D; Ikawa M; Fujii H; Yokoayama Y
    Mol Biol Rep; 2023 Jan; 50(1):531-540. PubMed ID: 36352178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Carbonyl Reductase 1 Safely Improves the Efficacy of Doxorubicin in Breast Cancer Treatment.
    Jo A; Choi TG; Jo YH; Jyothi KR; Nguyen MN; Kim JH; Lim S; Shahid M; Akter S; Lee S; Lee KH; Kim W; Cho H; Lee J; Shokat KM; Yoon KS; Kang I; Ha J; Kim SS
    Antioxid Redox Signal; 2017 Jan; 26(2):70-83. PubMed ID: 27357096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional regulation of the canine carbonyl reductase 1 gene (cbr1) by the specificity protein 1 (Sp1).
    Quiñones-Lombraña A; Cheng Q; Ferguson DC; Blanco JG
    Gene; 2016 Oct; 592(1):209-214. PubMed ID: 27506315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbonyl Reductase 1 Plays a Significant Role in Converting Doxorubicin to Cardiotoxic Doxorubicinol in Mouse Liver, but the Majority of the Doxorubicinol-Forming Activity Remains Unidentified.
    Breysse DH; Boone RM; Long CM; Merrill ME; Schaupp CM; White CC; Kavanagh TJ; Schmidt EE; Merrill GF
    Drug Metab Dispos; 2020 Mar; 48(3):187-197. PubMed ID: 31955137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The modulation of carbonyl reductase 1 by polyphenols.
    Boušová I; Skálová L; Souček P; Matoušková P
    Drug Metab Rev; 2015; 47(4):520-33. PubMed ID: 26415702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epigallocatechin gallate derivative Y6 reduces the cardiotoxicity and enhances the efficacy of daunorubicin against human hepatocellular carcinoma by inhibiting carbonyl reductase 1 expression.
    Zhou H; Fu LX; Li L; Chen YY; Zhu HQ; Zhou JL; Lv MX; Gan RZ; Zhang XX; Liang G
    J Ethnopharmacol; 2020 Oct; 261():113118. PubMed ID: 32621953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the Canine Anthracycline-Metabolizing Enzyme Carbonyl Reductase 1 (cbr1) and the Functional Isoform cbr1 V218.
    Ferguson DC; Cheng Q; Blanco JG
    Drug Metab Dispos; 2015 Jul; 43(7):922-7. PubMed ID: 25918240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
    Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
    J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in improved efficacy of doxorubicin chemotherapy in Cbr1+/- mice.
    Freeland MM; Angulo J; Davis AL; Flook AM; Garcia BL; King NA; Mangibin SK; Paul KM; Prosser ME; Sata N; Bentley JL; Olson LE
    Anticancer Drugs; 2012 Jul; 23(6):584-9. PubMed ID: 22343424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of carbonyl reductase 1 in drug discovery and development.
    Shi SM; Di L
    Expert Opin Drug Metab Toxicol; 2017 Aug; 13(8):859-870. PubMed ID: 28712324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chrysin induces autophagy-dependent ferroptosis to increase chemosensitivity to gemcitabine by targeting CBR1 in pancreatic cancer cells.
    Zhou L; Yang C; Zhong W; Wang Q; Zhang D; Zhang J; Xie S; Xu M
    Biochem Pharmacol; 2021 Nov; 193():114813. PubMed ID: 34673014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on reduction of S-nitrosoglutathione by human carbonyl reductases 1 and 3.
    Staab CA; Hartmanová T; El-Hawari Y; Ebert B; Kisiela M; Wsol V; Martin HJ; Maser E
    Chem Biol Interact; 2011 May; 191(1-3):95-103. PubMed ID: 21256830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human carbonyl reductase 1 upregulated by hypoxia renders resistance to apoptosis in hepatocellular carcinoma cells.
    Tak E; Lee S; Lee J; Rashid MA; Kim YW; Park JH; Park WS; Shokat KM; Ha J; Kim SS
    J Hepatol; 2011 Feb; 54(2):328-39. PubMed ID: 21056497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonyl reductase 1 as a novel target of (-)-epigallocatechin gallate against hepatocellular carcinoma.
    Huang W; Ding L; Huang Q; Hu H; Liu S; Yang X; Hu X; Dang Y; Shen S; Li J; Ji X; Jiang S; Liu JO; Yu L
    Hepatology; 2010 Aug; 52(2):703-14. PubMed ID: 20683966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human carbonyl reductase 1 participating in intestinal first-pass drug metabolism is inhibited by fatty acids and acyl-CoAs.
    Hara A; Endo S; Matsunaga T; El-Kabbani O; Miura T; Nishinaka T; Terada T
    Biochem Pharmacol; 2017 Aug; 138():185-192. PubMed ID: 28450226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-nitrosoglutathione covalently modifies cysteine residues of human carbonyl reductase 1 and affects its activity.
    Hartmanová T; Tambor V; Lenčo J; Staab-Weijnitz CA; Maser E; Wsól V
    Chem Biol Interact; 2013 Feb; 202(1-3):136-45. PubMed ID: 23295225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver.
    Kassner N; Huse K; Martin HJ; Gödtel-Armbrust U; Metzger A; Meineke I; Brockmöller J; Klein K; Zanger UM; Maser E; Wojnowski L
    Drug Metab Dispos; 2008 Oct; 36(10):2113-20. PubMed ID: 18635746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonyl Reductase 1 Attenuates Ischemic Brain Injury by Reducing Oxidative Stress and Neuroinflammation.
    Mao L; Wang K; Zhang P; Ren S; Sun J; Yang M; Zhang F; Sun B
    Transl Stroke Res; 2021 Oct; 12(5):711-724. PubMed ID: 33964000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of human carbonyl reductase 1 (CBR1, SDR21C1) gene by transcription factor Nrf2.
    Miura T; Taketomi A; Nishinaka T; Terada T
    Chem Biol Interact; 2013 Feb; 202(1-3):126-35. PubMed ID: 23247010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the anthracycline-metabolizing enzyme carbonyl reductase 1 in hearts from donors with Down syndrome.
    Kalabus JL; Sanborn CC; Jamil RG; Cheng Q; Blanco JG
    Drug Metab Dispos; 2010 Dec; 38(12):2096-9. PubMed ID: 20729274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.